{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:37:51Z","timestamp":1778650671361,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00296-017-3777-3","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T18:01:07Z","timestamp":1501092067000},"page":"1435-1440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Carly A.","family":"Janssen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim L. Th. A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn A. H.","family":"Oude Voshaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald E.","family":"Vonkeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart A. F. J.","family":"van de Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"key":"3777_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649\u2013662. doi: 10.1038\/nrrheum.2015.91","journal-title":"Nat Rev Rheumatol"},{"key":"3777_CR2","first-page":"1582","volume":"31","author":"KL Wallace","year":"2004","unstructured":"Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R (2004) Increasing prevalence of gout and hyperuricemia over 10\u00a0years among older adults in a managed care population. J Rheumatol 31:1582\u20131587","journal-title":"J Rheumatol"},{"key":"3777_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/acr.22660","volume":"68","author":"T Bardin","year":"2016","unstructured":"Bardin T, Bou\u00e9e S, Clerson P et al (2016) Prevalence of gout in the adult population of france. Arthritis Care Res 68:261\u2013266. doi: 10.1002\/acr.22660","journal-title":"Arthritis Care Res"},{"key":"3777_CR4","unstructured":"Jansen TL\u00a0(2016) Chapter 41 clinical presentation of gout. In: Doherty M, Hunter DJ, Bijlsma H, Arden N, Dalbeth N (eds) Oxford textbook of osteoarthritis and crystal arthropathy, 3rd edn. Oxford University Press, New York"},{"key":"3777_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3899\/jrheum.071229","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, Benjamin KL et al (2009) Quality of life and disability in patients with treatment-failure gout. J Rheumatol 36:1041\u20131048. doi: 10.3899\/jrheum.071229","journal-title":"J Rheumatol"},{"key":"3777_CR6","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312\u20131324. doi: 10.1136\/ard.2006.055269","journal-title":"Ann Rheum Dis"},{"issue":"Suppl.2","key":"3777_CR7","doi-asserted-by":"publisher","first-page":"ii9","DOI":"10.1093\/rheumatology\/kep087","volume":"48","author":"F Perez-Ruiz","year":"2009","unstructured":"Perez-Ruiz F (2009) Treating to target: a strategy to cure gout. Rheumatology 48(Suppl.2):ii9\u2013ii14. doi: 10.1093\/rheumatology\/kep087","journal-title":"Rheumatology"},{"key":"3777_CR8","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Khanna PP, Fitzgerald JD et al (2012) 2012 American college of rheumatology guidelines for management of gout. part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res 64:1447\u20131461. doi: 10.1002\/acr.21773","journal-title":"Arthritis Care Res"},{"key":"3777_CR9","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","volume":"71","author":"M Doherty","year":"2012","unstructured":"Doherty M, Jansen TL, Nuki G et al (2012) Gout: why is this curable disease so seldom cured? Ann Rheum Dis 71:1765\u20131770. doi: 10.1136\/annrheumdis-2012-201687","journal-title":"Ann Rheum Dis"},{"key":"3777_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M (2015) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 74:661\u2013667. doi: 10.1136\/annrheumdis-2013-204463","journal-title":"Ann Rheum Dis"},{"key":"3777_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301\u20131311. doi: 10.1136\/ard.2006.055251","journal-title":"Ann Rheum Dis"},{"key":"3777_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76:29\u201342. doi: 10.1136\/annrheumdis-2016-209707","journal-title":"Ann Rheum Dis"},{"key":"3777_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/annrheumdis-2016-209467","volume":"76","author":"U Kiltz","year":"2017","unstructured":"Kiltz U, Smolen J, Bardin T et al (2017) Treat-to-target (T2T) recommendations for gout. Ann Rheum Dis 76:632\u2013638. doi: 10.1136\/annrheumdis-2016-209467","journal-title":"Ann Rheum Dis"},{"key":"3777_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2296-14-170","volume":"14","author":"E Cottrell","year":"2013","unstructured":"Cottrell E, Crabtree V, Edwards JJ, Roddy E (2013) Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice. BMC Fam Pract 14:170. doi: 10.1186\/1471-2296-14-170","journal-title":"BMC Fam Pract"},{"key":"3777_CR15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1071\/HC09315","volume":"1","author":"B Arroll","year":"2009","unstructured":"Arroll B, Bennett M, Dalbeth N et al (2009) More allopurinol is needed to get gout patients <0.36\u00a0mmol\/L: a gout audit in the form of a before-after trial. J Prim Health Care 1:315\u2013318","journal-title":"J Prim Health Care"},{"key":"3777_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00296-009-1056-7","volume":"30","author":"GC Wall","year":"2010","unstructured":"Wall GC, Koenigsfeld CF, Hegge KA, Bottenberg MM (2010) Adherence to treatment guidelines in two primary care populations with gout. Rheumatol Int 30:749\u2013753. doi: 10.1007\/s00296-009-1056-7","journal-title":"Rheumatol Int"},{"key":"3777_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","volume":"12","author":"CA Sarawate","year":"2006","unstructured":"Sarawate CA, Patel PA, Schumacher HR et al (2006) Serum urate levels and gout flares analysis from managed care data. J Clin Rheumatol 12:61\u201365. doi: 10.1097\/01.rhu.0000209882.50228.9f","journal-title":"J Clin Rheumatol"},{"key":"3777_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/ard.2007.070755","volume":"66","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M (2007) Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 66:1311\u20131315. doi: 10.1136\/ard.2007.070755","journal-title":"Ann Rheum Dis"},{"key":"3777_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/00325481.2016.1113840","volume":"128","author":"P Khanna","year":"2016","unstructured":"Khanna P, Khanna D, Storgard C, Baumgartner S, Morlock R (2016) A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift. Postgrad Med 128:34\u201340. doi: 10.1080\/00325481.2016.1113840","journal-title":"Postgrad Med"},{"key":"3777_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/03007995.2016.1239193","volume":"33","author":"A Shiozawa","year":"2017","unstructured":"Shiozawa A, Buysman EK, Korrer S (2017) Serum uric acid levels and the risk of flares among gout patients in a US managed care setting. Curr Med Res Opin 33:117\u2013124. doi: 10.1080\/03007995.2016.1239193","journal-title":"Curr Med Res Opin"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3777-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T17:07:23Z","timestamp":1569949643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3777-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3777"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3777-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]}}}